The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Webcast
In this short webcast, Chris Wiekert, senior product manager at Infor, will take you through the steps he used to lead his department in a cul
Webcast
Susan Morris, CMRP, FAHRMM, health care executive, Cerner Corporation, explains the different parts of the Unique Device Identifier (UDI) and
Webcast
Get introduced to risk sharing in health care and learn how providers and suppliers can work together to generate financial, operational and clinic
Webcast
Data visualization can help translate dashboards, benchmarking and metrics lines, and lines of supply chain data into actionable insight.
Case Studies
WORK GROUP TITLE:UDI Capture Work GroupCASE STUDY PARTICIPANTS:
Pagination
- First page
- Previous page
- More previous pages available
- Page 30
- Page 31
- Page 32
- Page 33
- Current page 34
- Page 35
- Page 36
- Page 37
- Page 38
- More next pages available
- Next page
- Last page